TipRanks
Ionis Pharmaceuticals (DE:ISI)
XETRA:ISI
Germany Market
ISI
Ionis Pharmaceuticals
RESEARCH TOOLSreports

Ionis Pharmaceuticals (ISI) Stock News & Sentiment

5 Followers
Ionis: Partnered Royalty Strength and De-Risked Revenue Visibility Support Buy Rating; Price Target Reaffirmed at $100
Premium
Ratings
Ionis: Partnered Royalty Strength and De-Risked Revenue Visibility Support Buy Rating; Price Target Reaffirmed at $100
3d ago
IONS
Ionis Advances IgA Nephropathy Program With Positive Phase 3
Premium
Company Announcements
Ionis Advances IgA Nephropathy Program With Positive Phase 3
8d ago
8K
IONS
Ionis boosted by FDA approval of hepatitis B therapy
Premium
Company Announcements
Ionis boosted by FDA approval of hepatitis B therapy
10d ago
8K
IONS
Analyst Raises Ionis Price Target to $66 on Strong Tryngolza Launch and Undervalued sHTG Opportunity
Premium
Ratings
Analyst Raises Ionis Price Target to $66 on Strong Tryngolza Launch and Undervalued sHTG Opportunity
10d ago
IONS
3 Healthcare Stocks with Strong Buy Ratings and Double-Digit Upside
Premium
Market News
3 Healthcare Stocks with Strong Buy Ratings and Double-Digit Upside
10d ago
BSX
BMRN
Amprius, Viking, Regeneron, Ionis, Crispr Trending With Analysts
Premium
Weekend Updates
Amprius, Viking, Regeneron, Ionis, Crispr Trending With Analysts
15d ago
AMPX
CRSP
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
Premium
Market News
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
25d ago
AZN
MRK
More DE:ISI News >

ISI News on the Web

Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Ionis Pharmaceuticals partner GSK announces FDA approval of Hibsago
TipRanks News
Bullish
Alnylam vs. Ionis: Here's the Better Bad-News Buy
The Motley Fool
Neutral
Ionis Pharmaceuticals (IONS) Receives a Buy from Bank of America Securities
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Immunovant (IMVT) and Ionis Pharmaceuticals (IONS)
TipRanks News
Bullish
Ionis: Strong ALS Data and Underappreciated Pipeline Support Buy Rating and Unchanged $100 Price Target
TipRanks News
Bullish
Ionis Pharmaceuticals price target lowered to $70 from $76 at JPMorgan
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DE:ISI
Sector Average
Media Buzz
This Week8 articles
Weekly Average11 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:ISI’s Media Buzz Sentiment?
8 articles about DE:ISI were published this week. In an average week, 11 articles are published.
    What is DE:ISI’s weekly average amount of articles?
    In an average week, 11 articles about DE:ISI are published.
      What is DE:ISI’s News Sentiment?
      100% of articles about DE:ISI were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        GKOSGlaukos
        CNCCentene
        ASNDAscendis Pharma
        GILDGilead Sciences
        MRKMerck & Company
        Showing the stocks with the most bullish news sentiment over the past week